High integrin α3 expression is associated with poor prognosis in patients with non-small cell lung cancer

BACKGROUND: We previously showed that α3β1 integrin is a novel cancer biomarker and drug target in non-small cell lung cancer (NSCLC). This study characterized the integrin α3 (ITGA3) expression on patient specimens. METHODS: Tissue microarrays (TMAs) were prepared from archival tissue blocks contai...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qianping, Ma, Weijie, Chen, Shuai, Tian, Eddie C., Wei, Sixi, Fan, Reggie R., Wang, Tao, Zhou, Chihong, Li, Tianhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481578/
https://www.ncbi.nlm.nih.gov/pubmed/32953510
http://dx.doi.org/10.21037/tlcr-19-633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481578/
https://www.ncbi.nlm.nih.gov/pubmed/32953510
http://dx.doi.org/10.21037/tlcr-19-633

Ejemplares similares